Overview
Water (chemical formula: H2O) is a transparent fluid which forms the world's streams, lakes, oceans and rain, and is the major constituent of the fluids of organisms. As a chemical compound, a water molecule contains one oxygen and two hydrogen atoms that are connected by covalent bonds. Water is a liquid at standard ambient temperature and pressure, but it often co-exists on Earth with its solid state, ice; and gaseous state, steam (water vapor).
Indication
For diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered [FDA Label].
Associated Conditions
No associated conditions information available.
Research Report
A Comprehensive Pharmacological and Clinical Monograph on Water (DB09145)
I. Compound Identification and Physicochemical Profile
Water, the small molecule identified by DrugBank ID DB09145, is the most abundant chemical compound on Earth and is indispensable for all known forms of life.[1] While ubiquitous, in the context of medicine and pharmacology, it is treated as a distinct chemical entity with specific grades of purity, manufacturing standards, and clinical applications. Its unique physicochemical properties are the foundation of its physiological roles and its utility as a pharmaceutical agent. A precise understanding of its identity is therefore paramount.
1.1. Nomenclature and Identifiers
The extensive list of synonyms and identifiers for water reflects its multifaceted roles, from a fundamental chemical to a highly regulated pharmaceutical product. This nomenclature underscores the critical importance of specifying the purity and intended use in any clinical or research context. The proliferation of terms is not merely a matter of semantics but a direct consequence of the need to differentiate between water as a physiological substance and water as a manufactured product with stringent quality controls.[2]
- Primary Names: Water, Aqua [1]
- Systematic IUPAC Name: Oxidane [1]
- Common Chemical Names: Dihydrogen oxide, Dihydrogen Monoxide (DHMO), Hydrogen oxide [1]
- Pharmaceutical and Common Terms: A wide array of terms are used, often denoting purity or application, including Purified Water, Distilled Water, Deionized Water, Sterile Water, Water for Injection (WFI), Bacteriostatic Water for Injection, Sterile Water for Irrigation, and Water for Hemodialysis.[1]
- Database Identifiers:
- DrugBank ID: DB09145 [User Query]
- CAS Number: 7732-18-5 (primary registry number) [1]
- PubChem Compound ID (CID): 962 [6]
- European Community (EC) Number: 231-791-2 [1]
- UNII (Unique Ingredient Identifier): 059QF0KO0R [1]
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/07/31 | Not Applicable | Completed | Nanjing Children's Hospital | ||
2025/07/16 | Not Applicable | ENROLLING_BY_INVITATION | |||
2025/07/01 | Not Applicable | Not yet recruiting | |||
2025/02/03 | Phase 1 | Recruiting | |||
2024/09/19 | Phase 4 | Recruiting | |||
2024/07/24 | Phase 4 | Not yet recruiting | |||
2024/04/02 | Not Applicable | Not yet recruiting | |||
2023/11/18 | Phase 4 | Completed | |||
2023/10/04 | Not Applicable | Completed | |||
2023/09/29 | Not Applicable | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Bionpharma Inc. | 69452-378 | ORAL | N/A | 5/23/2023 | |
HF Acquisition Co LLC, DBA HealthFirst | 51662-1265 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1 mL in 1 mL | 2/21/2020 | |
TYA Pharmaceuticals | 64725-4887 | INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS | 1 mL in 1 mL | 9/15/2011 | |
Civica, Inc. | 72572-747 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1 mL in 1 mL | 4/7/2023 | |
A-S Medication Solutions | 50090-2874 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1 mL in 1 mL | 5/20/2021 | |
Henry Schein, Inc. | 0404-9970 | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 1 mL in 1 mL | 11/16/2023 | |
Nephron Pharmaceuticals Corporation | 0487-6105 | INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS | 1 mL in 1 mL | 6/4/2021 | |
Sandoz Inc | 0781-6021 | SUBCUTANEOUS, INTRAVENOUS | 1 mL in 1 mL | 10/3/2018 | |
GlaxoSmithKline LLC | 0173-0857 | INTRAVENOUS | 1 mL in 1 mL | 8/24/2021 | |
ICU Medical Inc. | 0990-7973 | IRRIGATION | 1 mL in 1 mL | 6/19/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
STERILE WATER FOR INJECTION USP | SIN10218P | INJECTION | 100% | 10/8/1998 | |
WATER FOR INJECTIONS BP | SIN06427P | INJECTION | 100% | 7/8/1991 | |
Sterile Diluent Syringe for Merck Sharp & Dohme | SIN13398P | INJECTION | 0.85 ml | 1/21/2008 | |
Sterile Diluent Vial for Merck Sharp & Dohme | SIN13397P | INJECTION | 0.85 ml | 1/21/2008 | |
WATER FOR INJECTION | SIN09577P | INJECTION | 100% | 12/15/1997 | |
STERILE WATER FOR INJECTION | SIN10403P | INJECTION | 100% | 11/11/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
PRIORIX POWDER FOR INJ VACCINE (LIVE) | N/A | N/A | N/A | 11/5/1998 | |
ALTUVIIIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 3000IU | N/A | N/A | N/A | 10/10/2024 | |
SONAZOID POWDER AND SOLVENT FOR DISPERSION FOR INJECTION 16 MICROLITRES | N/A | N/A | N/A | 3/4/2025 | |
SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 60MG | N/A | N/A | N/A | 10/13/2016 | |
ADYNOVATE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/2ML | N/A | N/A | N/A | 2/27/2023 | |
ALTUVIIIO POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU | N/A | N/A | N/A | 10/10/2024 | |
PRIORIX-TETRA VACCINE | N/A | N/A | N/A | 5/5/2009 | |
CABAZITAXEL CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION 60MG/1.5ML | N/A | N/A | N/A | 10/2/2024 |
TGA Drug Approvals
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
MEASLES VIRUS VACCINE, LIVE, ATTENUATED (DRIED) | connaught laboratories ltd. | 02215675 | Powder For Solution
,
Liquid
,
Kit - Subcutaneous | 0.6 ML / KIT | 12/11/1996 |
ANTITHROMBIN III IMMUNO | 02237812 | Powder For Solution - Intravenous | 30 ML / KIT | 7/5/1999 | |
HOMEOPATHIC MEDICINE (S NO. 324) DPS 30C | total health centre | 02077272 | Drops - Oral | 30 C / ML | 12/31/1994 |
OGIVRI | 02474433 | Powder For Solution - Intravenous | 20 ML / VIAL | 6/6/2019 | |
OMNITROPE | 02325055 | Kit
,
Powder For Solution - Subcutaneous | 1.14 ML / CARTRIDGE | N/A | |
INSTILLATION MEDIUM FOR IMMUCYST | aventis pasteur limited | 01974505 | Liquid - Intravesicular | 100 % / 50 ML | 12/31/1994 |
INTRON A - KIT (PWS+DILUENT) 5000000IU/VIAL | schering-plough (brinny) co. | 02223392 | Powder For Solution
,
Liquid - Intralesional
,
Subcutaneous
,
Intramuscular | 1 ML / VIAL | 12/31/1998 |
STERILE WATER FOR INJECTION USP | 02142546 | Solution - Intramuscular
,
Subcutaneous
,
Intraperitoneal
,
Intravenous | 100 % | 12/15/1994 | |
STERILE WATER FOR IRRIGATION USP | ICU Medical Canada Inc | 00498785 | Liquid - Irrigation
,
Intraperitoneal | 100 % | 12/31/1980 |
STEMGEN | biovitrum ab (publ) | 02240229 | Powder For Solution
,
Kit - Subcutaneous | 5 ML / VIAL | 9/20/1999 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.